Halozyme raises 2026 guidance, total revenue seen up to $1.925 billion
FROM THE WIRE · PRNEWSWIRE.COM
Total Revenue Increased 39% YOY to $493 million Royalty Revenue Increased 44% YOY to $341 million Raising 2026 Financial Guidance Ranges: Total Revenue of $1.860 - $1.925 billion, YOY Growth of 33% - 38% Royalty Revenue of $1.235 - $1.255 billion, YOY Growth of 42% - 45%…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRaising all major 2026 guidance lines is a positive factor for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Total revenue rose 39% year over year to $493 million in Q3.
- 02Royalty revenue increased 44% year over year to $341 million.
- 03Three ENHANZE programs advanced into Phase 1 clinical development.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets